Investigating the cumulative effects of Delta 9-tetrahydrocannabinol and repetitive mild traumatic brain injury on adolescent rats
AuthorBhatt, D; Hazari, A; Yamakawa, GR; Salberg, S; Sgro, M; Shultz, SR; Mychasiuk, R
Source TitleBrain Communications
PublisherOXFORD UNIV PRESS
University of Melbourne Author/sShultz, Sandy
AffiliationMedicine and Radiology
Document TypeJournal Article
CitationsBhatt, D., Hazari, A., Yamakawa, G. R., Salberg, S., Sgro, M., Shultz, S. R. & Mychasiuk, R. (2020). Investigating the cumulative effects of Delta 9-tetrahydrocannabinol and repetitive mild traumatic brain injury on adolescent rats. BRAIN COMMUNICATIONS, 2 (1), https://doi.org/10.1093/braincomms/fcaa042.
Access StatusOpen Access
The prevalence of mild traumatic brain injury is highest amongst the adolescent population and can lead to complications including neuroinflammation and excitotoxicity. Also pervasive in adolescents is recreational cannabis use. Δ9-Tetrahydrocannabinol, the main psychoactive component of cannabis, is known to have anti-inflammatory properties and serves as a neuroprotective agent against excitotoxicity. Thus, we investigated the effects of Δ9-tetrahydrocannabinol on recovery when administered either prior to or following repeated mild brain injuries. Male and female Sprague-Dawley rats were randomly assigned to receive Δ9-tetrahydrocannabinol or vehicle either prior to or following the repeated injuries. Rats were then tested on a behavioural test battery designed to measure post-concussive symptomology. The hippocampus, nucleus accumbens and prefrontal cortex were extracted from all animals to examine mRNA expression changes (Bdnf, Cnr1, Comt, GR, Iba-1 and Vegf-2R). We hypothesized that, in both experiments, Δ9-tetrahydrocannabinol administration would provide neuroprotection against mild injury outcomes and confer therapeutic benefit. Δ9-Tetrahydrocannabinol administration following repeated mild traumatic brain injury was beneficial to three of the six behavioural outcomes affected by injury (reducing anxiety and depressive-like behaviours while also mitigating injury-induced deficits in short-term working memory). Δ9-Tetrahydrocannabinol administration following injury also showed beneficial effects on the expression of Cnr1, Comt and Vegf-2R in the hippocampus, nucleus accumbens and prefrontal cortex. There were no notable benefits of Δ9-tetrahydrocannabinol when administered prior to injury, suggesting that Δ9-tetrahydrocannabinol may have potential therapeutic benefit on post-concussive symptomology when administered post-injury, but not pre-injury.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References